Sponsor pipeline

Sangamo Therapeutics clinical trial pipeline

Get alerts when Sangamo Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1/2
1
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06980948 Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy… Chronic Neuropathic Pain Recruiting 2026-06-01
Not specified
NCT05039866 Long-Term Follow-up of Subjects Who Were Treated With ST-920 Fabry Disease Active, Not Recruiting 2026-08-20
NCT05987527 Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term) Kidney Transplant Rejection Active, Not Recruiting 2025-12-04
NCT05145062 Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously… Blood and Lymphatic Diseases Active, Not Recruiting 2025-11-12

Disease areas by active trials

Chronic Kidney Disease (1) · Sickle Cell Disease (1) · Thalassemia (1)

Get alerts when Sangamo Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free